Pilot trial of plant-derived recombinant type I human collagen in healing post-surgical diabetic foot wounds

Article points 1. Plant-derived recombinant type I human collagen has similar properties to human collagen and is not associated with the adverse effects of cadaveror animal-derived collagen. 2. The addition of recombinant collagen to standard care was studied to determine its effect on healing rate and time. 3. Recombinant collagen was associated with significantly shorter healing times and a higher rate of complete healing versus standard care without causing any adverse events. 4. Recombinant collagen is effective in the treatment of post-surgical diabetic foot wounds.